Stephania abyssinica
Stephania abyssinica · Accepted scientific name
Scientific literature: Very Sparse (3 studies) · ★☆☆☆☆
Stephania abyssinica is a botanical species that has garnered significant scientific interest due to its diverse pharmacological potential. Researchers primarily focus on the medicinal properties of its leaves, which serve as the main source for various therapeutic studies. Through the use of preparations such as aqueous extracts and organic solvents, scientists have explored the plant's complex chemical profile. These investigations have specifically highlighted the plant's notable vasorelaxant and antihypertensive activities. Consequently, these findings suggest that extracts of Stephania abyssinica could play a role in managing cardiovascular health.
- Synonyms
- Clypea Abyssinica · Stephania Hernandiifolia Var. Abyssinica
- Common names
- Not available
- Family
- Menispermaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Stephania abyssinica is a fascinating plant known by a diverse array of regional names. It is frequently referred to as Abissin stefaniyası in certain botanical circles. Locally, many people recognize the species by its common name, Gbejedi. Other traditional labels used to identify this plant include Labororiet and Lokitimu. Finally, it is also widely known by the name Ndabararia.
Sources: Catalogue of Life (COL)
Synonyms
Stephania abyssinica is a botanical subject that carries several important taxonomic designations within scientific literature. It is formally recognized as having the synonym Clypea abyssinica, reflecting historical shifts in its classification. Furthermore, the plant is also identified by the synonymous name Stephania hernandiifolia var. abyssinica. Understanding these varying names is essential for researchers tracking the species' evolutionary history. These nomenclatural connections ensure that botanical data remains consistent across different studies.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Stephania abyssinica is a remarkable member of the kingdom Plantae. This unique species is classified within the class Equisetopsida and belongs to the order Ranunculales. Within this botanical hierarchy, it is further categorized under the family Menispermaceae. It also holds a specific place within the genus Stephania. Understanding these biological relationships provides essential insight into its place in the natural world.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ranunculales |
| Family | Menispermaceae |
| Genus | Stephania |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Stephania abyssinica is a notable plant species with a significant presence across the African continent. Its natural distribution spans much of East Tropical Africa, including the countries of Kenya, Tanzania, and Uganda. Additionally, the species can be found extending into Northeast Tropical Africa. This broader range encompasses the regions of Eritrea and Ethiopia. Collectively, these locations highlight the plant's important ecological footprint within these diverse African landscapes.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Stephania abyssinica is characterized by an obligatory climbing habit that allows it to ascend toward light sources. This climbing species exhibits significant variability in its physical stature depending on its environment. While some individuals may only reach a minimum height of 1 meter, others can grow much larger. Ultimately, these plants typically scale between 5 and 9.14 meters in height.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Stephania abyssinica is a medicinal plant traditionally utilized in Cameroon to treat arterial hypertension. Scientific investigations have demonstrated that its leaf aqueous extract possesses significant vasorelaxant activity, working through mechanisms that are independent of the endothelium and nitric oxide pathways. This extract effectively produces concentration-dependent relaxation in aortic rings by inhibiting intracellular calcium release and potentially activating ATP-sensitive potassium channels. Furthermore, in vivo studies confirm that the plant exerts a potent antihypertensive effect by reducing blood pressure, heart rate, and ventricular hypertrophy. These combined pharmacological properties support the potential of Stephania abyssinica as a valuable candidate for managing hypertension and protecting cardiovascular health.
Compounds
Conditions
Stephania abyssinica demonstrates significant therapeutic potential by treating arterial hypertension through its vasorelaxant properties. The plant's aqueous extract effectively treats KCl-induced contraction by inhibiting intracellular calcium release. Research further indicates that its administration can ameliorate heart and kidney lesions in hypertensive models. Additionally, the plant exhibits potent anti-plasmodial activity against both chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum. These diverse medicinal effects highlight its utility in treating cardiovascular conditions and malaria.
Preparations
Stephania abyssinica is prepared as AESA to study its potential antihypertensive and vasorelaxant properties. This specific plant material is also prepared as a leaf aqueous extract for use in medicinal research. Furthermore, the plant is prepared as organic and aqueous extracts to evaluate its anti-plasmodial activity against malaria strains. These various preparation methods allow researchers to explore the plant's diverse therapeutic applications. By utilizing these different extract forms, the medicinal value of the species can be assessed for different health conditions.
Parts used
Stephania abyssinica is a medicinal plant widely utilized in Cameroon to treat arterial hypertension. Research focuses specifically on the aqueous extract derived from the plant's leaf to explore its therapeutic potential. Studies have demonstrated that this leaf extract possesses significant vasorelaxant properties that function independently of the endothelium nitric oxide pathway. Through various pharmacological tests, it has been shown that the extract can effectively reduce blood pressure and heart rate in animal models. These findings suggest that the bioactive compounds found in the leaf of Stephania abyssinica could serve as a promising basis for new antihypertensive drugs.